Table 4 Multivariate logistic regression for colitis risk

Characteristic

OR (95% CI)

P

Race (Caucasian)

5.76 (2.03–16.36)

0.001

Cancer stage IV

0.09 (0.03–0.30)

< 0.001

Cancer type (Melanoma)

1.96 (1.04–3.67)

0.037

ICPI agent

 Ipilimumab + combination

2.23 (1.03–4.81)

0.041

 Nivolumab

0.39 (0.14–1.11)

0.079

Duration of ICPI treatment

0.99 (0.99–1.00)

0.049